Apple supplier Skyworks Solutions saw its stock drop nearly 25% Thursday as the semiconductor firm said that it's losing ...

TD Cowen analysts view Sen. Dan Sullivan’s proposed missile defense legislation as a long-term catalyst for major U.S. defense contractors, with Lockheed Martin (NYSE:LMT), Northrop Grumman (NYSE:NOC) ...

As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scaliaasked CEO David Ricks if the company ...

TD Cowen analyst Bryan Bergin updated the financial outlook for Cognizant Technology Solutions (NASDAQ:CTSH), increasing the ...

TD Cowen analyst Phil Nadeau maintained a Buy rating on Kura Oncology (KURA – Research Report) today. The company’s shares closed yesterday at ...

TD Cowen analyst Andrew Kligerman maintained a Hold rating on AFLAC (AFL – Research Report) today and set a price target of $98.00. The ...

Seeing “growth on hiatus,” Mr. Bir reduced his own forecast for 2025 and 2026 “with revisions mainly for longer lease-up ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry Genetics ...

Noting that Ambry is a profitable testing laboratory that generates more than $300 million of revenue annually, the investment bank thinks that the deal will enable TEM to start generating positive ...